CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,285,604
- in 7 filings, $33.3M under 10b5-1 plans
Net −$33,285,604. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-05 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion 10b5-1 | +2,207 | $106.47 | $235K | 63,648 |
| 2026-08-05 | Mayes Patrick A EVP & Chief Scientific Officer | Sale 10b5-1 | −2,207 | $123.99 | $274K | 61,441 |
| 2026-08-05 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) 10b5-1 | −2,207 | 0 | ||
| 2026-08-03 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion 10b5-1 | +6,055 | $105.43 | $638K | 67,496 |
| 2026-08-03 | Mayes Patrick A EVP & Chief Scientific Officer | Sale 10b5-1 | −6,055 | $120.43 | $729K | 61,441 |
| 2026-08-03 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) 10b5-1 | −6,055 | 0 | ||
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion 10b5-1 | +2,918 | $61.18 | $179K | 66,546 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion 10b5-1 | +2,284 | $64.25 | $147K | 68,830 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion 10b5-1 | +2,709 | $61.76 | $167K | 71,539 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion 10b5-1 | +3,148 | $68.62 | $216K | 74,687 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion 10b5-1 | +2,072 | $71.93 | $149K | 76,759 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion 10b5-1 | +9,459 | $72.27 | $684K | 86,218 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion 10b5-1 | +2,623 | $74.78 | $196K | 88,841 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion 10b5-1 | +2,864 | $77.67 | $222K | 91,705 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion 10b5-1 | +1,643 | $80.50 | $132K | 93,348 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion 10b5-1 | +3,023 | $83.20 | $252K | 96,371 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion 10b5-1 | +2,623 | $83.58 | $219K | 98,994 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion 10b5-1 | +1,642 | $85.01 | $140K | 100,636 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion 10b5-1 | +2,293 | $90.56 | $208K | 102,929 |
| 2026-07-31 | Mayes Patrick A EVP & Chief Scientific Officer | Exercise or conversion 10b5-1 | +85 | $106.47 | $9K | 103,014 |
Page 1 of 3 · 57 trades